AbbVie completes acquisition of Landos Biopharma to strengthen immunology portfolio
AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has announced the completion of its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company, ... Read More
Suven Pharmaceuticals and Cohance Lifesciences announce merger
In a significant development in the pharmaceutical industry, Suven Pharmaceuticals Limited (Suven) and Cohance Lifesciences Limited (Cohance) have announced a proposed scheme of amalgamation, marking ... Read More
Roche to acquire Ignyta for $1.7bn to enhance oncology portfolio
Roche Pharmaceuticals, a prominent Swiss pharmaceutical company, has entered into a definitive merger agreement to acquire Ignyta, a U.S. cancer drug maker, for $1.7 billion ... Read More